Yes it is. I believe it is a new position and sheds some light on who was buying the past quarter. There is no doubt Anavex is getting recognized. Both in the industry, with the Biogen MTA, and on Wall Street with Noble and now, Park West Asset. All we need now is for the trials to confirm what we have seen in pre-clinical's. Patience and hope.
News 
Market Data 
Discover 
AI
